Company Overview
Calumet, Inc. manufactures, formulates, and markets a slate of specialty branded products and renewable fuels in North America and internationally. It operates through Specialty Products and Solutions; Performance Brands; and Montana/Renewables segments. The Specialty Products and Solutions segment manufactures and markets various solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. The Montana/Renewables segment processes geographically advantaged renewable feedstocks into renewable diesel, aviation fuel, and renewable naphtha. This segment also engages in the process of Canadian crude oil into conventional gasoline, diesel, jet fuel, and specialty grades of asphalt. The Performance Brands segment blends, packages, and markets high performance products through Royal Purple, Bel-Ray, and TruFuel brands. It serves wholesale distributors and retail chains. Calumet, Inc. was founded in 1919 and is headquartered in Indianapolis, Indiana.
Why Investors Should Care
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $4.14B (-1.2% YoY); net profit $-33.80M.
- Trailing 12 Months Year-on-year growth — revenue +3.6%.
- 5-Year Trend Long-term compounding — revenue CAGR -4.1%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -4.07% |
| 1 Year: | 3.60% |
Stock Price Performance
| 1 Year: | +141.58% |
| 6 Months: | +99.14% |
| 3 Months: | +20.27% |
| 1 Month: | +13.32% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- RSI (14)74.56 · Overbought
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
- In a confirmed uptrend (50-DMA above 200-DMA).
CONS
- Revenue declined at -4.1% CAGR over 5 years.
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Peer comparison
Peer companies in the same sector (Basic Materials).
| # | Name | CMP $ | P/E | Mkt Cap | Div Yld % | ROCE % | ROE % | Rev CAGR 5Y % | Profit CAGR 5Y % |
|---|---|---|---|---|---|---|---|---|---|
| 1 | CLMT Calumet, Inc. R2K | 39.57 | -18.32 | $3.45B | 0.00% | 5.88% | 4.61% | -4.07% | - |
| 2 | LIN Linde plc NDXSPX | 522.54 | 34.65 | $241.59B | 1.22% | 12.46% | 18.23% | 13.90% | 18.47% |
| 3 | NEM Newmont Corporation SPX | 94.75 | 12.29 | $101.15B | 1.04% | - | 25.83% | 6.53% | 20.15% |
| 4 | FCX Freeport-McMoRan Inc. SPX | 61.95 | 32.78 | $89.06B | 0.88% | 12.50% | 15.63% | 1.35% | -1.26% |
| 5 | SHW The Sherwin-Williams Company SPX | 328.50 | 31.56 | $81.02B | 1.01% | 21.93% | 60.72% | 6.18% | 8.26% |
| 6 | ECL Ecolab Inc. SPX | 269.75 | 36.55 | $75.92B | 1.10% | 14.29% | 22.43% | 6.17% | 9.18% |
| 7 | CRH CRH plc SPX | 103.91 | 19.28 | $69.43B | 1.47% | 10.97% | 15.81% | 6.41% | 9.30% |
| 8 | APD Air Products and Chemicals, Inc. SPX | 299.40 | 31.55 | $66.67B | 2.57% | -0.62% | 12.35% | -1.77% | -39.16% |
| 9 | CTVA Corteva, Inc. SPX | 84.91 | 45.90 | $56.79B | 0.95% | - | 5.14% | 2.86% | 9.94% |
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.15B | 1.01B | 1.13B | 1.10B | 993.90M | 1.03B | 1.08B | 1.03B |
| Gross Profit | 261.50M | 78.50M | 63.80M | 4.90M | -81.40M | -43.60M | 373.70M | -87.50M |
| Operating Income | 213.00M | 36.30M | 6.20M | -57.10M | -48.70M | -101.00M | 322.90M | -171.30M |
| Net Income | 99.80M | -41.60M | -39.10M | -100.60M | -162.00M | -147.90M | 313.40M | -317.00M |
| Diluted EPS | 1.24 | -0.51 | -0.48 | -1.18 | -1.87 | -1.70 | 3.61 | -3.64 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Revenue | 4.69B | 4.18B | 4.19B | 4.14B |
| Gross Profit | 351.70M | 451.70M | 230.80M | 245.70M |
| Operating Income | 131.90M | 267.20M | 8.10M | 108.70M |
| Net Income | -173.30M | 48.10M | -222.00M | -33.80M |
| Diluted EPS | - | - | -2.67 | -0.39 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | - | 2.75B | 2.76B | 2.69B |
| Total Equity | -385.10M | -533.30M | -490.30M | -711.90M | -732.70M |
| Cash & Equivalents | - | 35.20M | 7.90M | 38.10M | 125.10M |
| Long Term Debt | - | - | 1.83B | 2.06B | 2.08B |
| Total Liabilities | - | - | 3.00B | 3.22B | 3.18B |
| Current Liabilities | - | - | 1.11B | 863.60M | 840.70M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Operating Cash Flow | 100.60M | -14.90M | -46.40M | 108.90M |
| Investing Cash Flow | -536.00M | -271.80M | -76.70M | 44.10M |
| Financing Cash Flow | 348.70M | 266.20M | 154.30M | 6.20M |
| Capital Expenditure | -536.20M | -271.80M | -76.70M | -52.30M |
| Free Cash Flow | -435.60M | -286.70M | -123.10M | 56.60M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|
| Gross Margin % | 7.5% | 10.8% | 5.5% | 5.9% |
| Operating Margin % | 2.8% | 6.4% | 0.2% | 2.6% |
| Net Margin % | -3.7% | 1.2% | -5.3% | -0.8% |
| ROE % | 32.5% | -9.8% | 31.2% | 4.6% |
| ROCE % | - | 16.3% | 0.4% | 5.9% |
Shareholding Pattern
Top Institutional Holders
| # | Holder | % Held | Shares | Value |
|---|---|---|---|---|
| 1 | Two Seas Capital Lp | 6.84% | 5.96M | $217.13M |
| 2 | Blackrock Inc. | 5.72% | 4.98M | $181.44M |
| 3 | Wasserstein Management, L.P | 5.25% | 4.57M | $166.61M |
| 4 | Vanguard Capital Management LLC | 3.94% | 3.44M | $125.15M |
| 5 | Adams Asset Advisors, LLC | 3.67% | 3.20M | $116.66M |
| 6 | State Street Corporation | 3.53% | 3.08M | $112.21M |
| 7 | Geode Capital Management, LLC | 2.15% | 1.87M | $68.23M |
| 8 | Bank of America Corporation | 1.32% | 1.15M | $42.03M |
| 9 | Morgan Stanley | 1.21% | 1.05M | $38.32M |
| 10 | Vanguard Portfolio Management LLC | 1.07% | 930.25K | $33.89M |
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for CLMT
Is Calumet, Inc. (CLMT) Outperforming Other Oils-Energy Stocks This Year? - Yahoo Finance Singapore
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOX1FRUWV5c1d6eldtazE4amZEM3BRNGdiZ2tpazZXeGtwMkRlNExDVE9mVER5V3AwVXNyNmw0Yl9LWU5QWnBYT1NXdHVxM0pxbWZ6c3FzMFFIRlUxaHFFa1pXeF93MHBkd3JXUkZvcUl1b1ZFVjhORlZVeUNhZzYtT0I0X1dOTzFtbGxtU1…
Calumet, Inc. (CLMT) director exercises 7,067 RSUs into common shares - Stock Titan
<a href="https://news.google.com/rss/articles/CBMirAFBVV95cUxOQzFTcnNWMm1DWFpKenZwb2tTcHdzMlY0WkVhYjJMRV85VjN3MldCZ0E2bG5pLVgyNnd4REVEVHlTZGxLN2NMZHR1aVM4a2ZCUVg3Zm5naVY4UUFDa1paa1VCRjVqTVA4eXVqc2dteXRIdUVNWTlzM3o3VU1nSS1HdTVXWG1XMDBoTFFab2…
Calumet, Inc. (NASDAQ:CLMT) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPVVZ6NzBKVW1sZzNqc28wbExtbVpiQ3ZUV0JtNjFNOF9JZW1tREtsV2dQZUdxekVCZW5fTy1aY1ljWjZCbkRkYnVtT1pTMjc2a2tEMm8yV04wU3VEQ0kwel81cFhWOHJDWWZMQ1J5M2Q2Yld1YUw1MVpkZ05xWEJ2aWYwNFFuSmVEeGFQRG…
CLMT Stock Price, Chart, and Forecast - Moomoo
<a href="https://news.google.com/rss/articles/CBMioAJBVV95cUxPYzdrVEVDMDRtZzVpN052aUhUZW1kQ3VCNGtLRlRKeGxLVmR4by1LNUFVdXFuekFHSm03VEFGVzZwMzV0S3JmcENSQTVIa19aMFpMbnJtQW8talIwYzdZTEtMY2pJeDVCNG43T0NHclYyWmxwWUEweWhVQ3lfWU5iZVJENkg3RzBfOFctRF…
Why Calumet (CLMT) Shares Are Trading Lower Today - StockStory
<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxPRUhTOU9KZTB0cTZwMXhySl9pSmlDLVU3WmFVdWp1aUNUcXlyRk1yTG5maDV6Y2Q1UmY3bkdlbjBrTXZ1OHF0WHhfNXhOMnJ5YzZLTXNDRnd2QjVwSVZTSkJZT1pVdFhSMjFZT0FsZktHRWFQZDFwNWZPY24tVk5DblN0MWxCRWZlUVp1b3…
CLMT Forecast — Price Target — Prediction for 2027 - TradingView
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE5aUXhfc012LXhpMktzRjIxb0pDTnhXRnpCYjhqZXdXWWlFSXM0c19mQlpyWGV1MGZ4Zmk4a2VZbUxhLTR0M1FQYUxUSmlkWW9Xdm5QLUdHamtfaHR0REFDc3E2VXNiQUpZQk4xUTY1S25LOVFTcGdVaWZB?oc=5" target="_blank">CLM…
CLMT — Frequently Asked Questions
What is the current share price of Calumet, Inc. (CLMT)?
As of 2026-07-14 21:23 PDT, Calumet, Inc. (CLMT) trades at $39.57 on NasdaqGS. Its 52-week range is $13.23 to $39.58.
What is the market capitalisation of CLMT?
Calumet, Inc. (CLMT) has a market capitalisation of $3.45B on NasdaqGS.
What is the P/E ratio of CLMT?
CLMT trades at a trailing price-to-earnings (P/E) ratio of -18.32. The industry average P/E is 22.91. Its price-to-book (P/B) ratio is -2.87.
What is the return on equity (ROE) of CLMT?
CLMT has a return on equity (ROE) of 4.61%. Its return on capital employed (ROCE) is 5.88%.
Is CLMT a good stock to buy?
This page provides a data-driven analysis of Calumet, Inc. (CLMT), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.